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Though the surgical treatment for medial temporal lobe epilepsy yields a high success rate, more studies are needed in order to
determine the most efficacious pre-operative algorithm. The authors studied the relationship between surgical outcome and the
localization results of various pre-operative diagnostic tests to assess the predictive value.
Seventy-one consecutive patients who had undergone anterior temporal lobectomy with amygdalohippocampectomy with
the diagnosis of non-lesional medial temporal lobe epilepsy, who had been followed up more than 24 months, were analyzed
retrospectively. Electroencephalogy (EEG), magnetic resonance imaging (MRI), proton emission tomography (PET), single
photon emission computed tomography (SPECT), the Wada test, and neuropsychological testing were analyzed.
There was no diagnostic test that was found to have a statistically significant relationship between Engel Class I outcome and
localization results (P > 0.05). SPECT, neuropsychological testing, and the Wada test all had less predictive values (P < 0.01).
EEG and PET had comparable predictive values for Engel Class I with MRI (P > 0.05).
No single diagnostic test alone is sufficient to make a diagnosis of non-lesional medial temporal lobe epilepsy. MRI, EEG
and PET had comparable predictive values for Engel Class I. SPECT, neuropsychological testing, and the Wada test had less
predictive values.
c© 1999 BEA Trading Ltd
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The paradigm for assessing patients prior to epilepsy
surgery varies widely depending on each individual
institution. In order to decrease medical costs and
to decrease the pre-operative evaluation period, we
need to determine the most efficacious pre-operative
algorithm and eliminate redundant tests1. Anterior
temporal lobectomy with amygdalohippocampectomy
is a safe and effective surgical treatment widely
performed for medically refractory medial temporal
lobe epilepsy. Though the surgical treatment for me-
dial temporal lobe epilepsy results in a high suc-
cess rate, more studies are needed to determine the
most efficacious pre-operative algorithm. A litera-
ture review suggests that proton emission tomogra-
phy (PET) and magnetic resonance imaging (MRI)
are much more sensitive to mesial temporal scle-1059–1311/99/080465 + 06 $12.00/0rosis (MTS) than single photon emission computed
tomography (SPECT)2–10. MRI-identified unilateral
hippocampal atrophy11–13, restrictive temporal lobe
hypometabolism by PET analysis14, febrile convul-
sions11, Wada memory performance15, and electroen-
cephalography (EEG) localization to temporal lobe
only11, 16 were found to be significant predictors of
good post-operative outcome, using bivariate analy-
sis. By using multivariate analysis, the percentage of
epileptic EEG activity arising from the site of resec-
tion, and either imaging localization or lack of the
use of invasive monitoring, were the only statistically
significant pre-operative predictors for good outcome
at 2 years17. Therefore, diagnostic tests with statis-
tically significant prognostic importance are thought
to be MRI, PET, the Wada test, and EEG. The
diagnostic tests, however, were not always redun-
dant.c© 1999 BEA Trading Ltd
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single diagnostic indicator for medial temporal lobe
epilepsy until now has led the authors to study the re-
lationships between surgical outcome and the local-
ization results of various diagnostic tests, in order to
assess the predictive value of each diagnostic test. We
hypothesized that MRI is the most important diagnos-
tic test and that EEG, PET, SPECT, the Wada test,
neuropsychological testing, and even ictal EEG con-
tribute no additional diagnostic efficacy.
MATERIALS AND METHODS
Patients
Seventy-one consecutive patients who underwent stan-
dard anterior temporal lobectomy along with amyg-
dalohippocampectomy with the diagnosis of medial
temporal lobe epilepsy were studied. Patients in whom
extrahippocampal focal epileptogenic lesions, such
as tumors, vascular malformations, developmental
anomalies, and malacia were seen on MR images were
excluded. The group of patients included 45 males
and 26 females, ranging in age from 11 to 51 years
(mean age, 28.9 years). All the patients were followed
for more than 24 months post-operatively at Seoul
National University Hospital Comprehensive Epilepsy
Program from September 1994 to March 1999. The
mean duration of follow-up was 38.4 months, ranging
from 24 to 60 months.
Pre-operative evaluation protocol
Evaluation protocol included a routine history, phys-
ical and neurological examination, prolonged inter-
ictal EEG, ictal video-EEG monitoring (of at least
three usual seizures), MRI for specific hippocampal
sequence, PET, interictal and ictal SPECT, the Wada
test, and neuropsychological testing.
MRI protocol is described in detail by Cheon et
al.18. Briefly, all MRI studies were performed on
either 1.5-T or 1.0-T units and T1-weighted sagit-
tal sequences and proton density- and T2-weighted
axial fast spin-echo sequences were obtained with
5 mm section thicknesses. Oblique coronal images
were obtained perpendicular to the long axis of
the hippocampus with 2-mm-thick T1-weighted 3D
magnetization-prepared rapid acquisition gradient-
echo sequences and 3-mm-thick T2-weighted fast
spin-echo sequences. The MR diagnosis of hippocam-
pal sclerosis was based on the presence of either uni-
lateral atrophy, high T2 signal intensity of the hip-
pocampus, or both, and on the absence of any other
abnormality.Lee et al.19 have described PET protocol in de-
tail. Briefly, after preliminary transmission scans
with use of germanium-68 (Ge-68), patients un-
derwent injection of 10 mCi (370 MBq) F-18-
fluorodeoxyglucose (FDG). PET was begun 40 min-
utes after F-18 FDG had been administered.
Lee et al.19 have described SPECT protocol
in detail. Briefly, interictal SPECT was done at
10 minutes after intravenous administration of
1110 MBq of Technetium-99m hexamethylepropyle-
neamine oxime (HMPAO). Patients who were to un-
dergo ictal SPECT were monitored with synchro-
nized video and EEG in the Epilepsy Monitoring
Unit (EMU). Soon after seizure onset, Tc-99m HM-
PAO was administered intravenously and ictal SPECT
were acquired from 30 minutes to 2 hours after the
seizure calmed down.
The Wada test was done for evaluation of language
and memory with concurrent scalp EEG recording.
After puncture of the femoral artery, a catheter tip was
positioned 5 cm 43 distal to the carotid bifurcation, at
first ipsilaterally to the presumed epileptic focus. Dig-
ital subtraction angiography was performed with pres-
surized injection of contrast medium. Then, while the
patient raised both arms and loudly counted backward
from 100, a bolus of 80–120 mg sodium amobarbital
was injected through the internal carotid artery over a
period of 3 to 5 seconds, until the contralateral hemi-
plegia was obtained. Ten stimulus cards were used to
evaluate memory function: five common objects, one
word, one phrase, one colored object, one geographic
object, and one mathematical expression. Each card
was presented a sufficient number of times on the side
contralateral to hemiparesis. While the memory stim-
uli were being presented, evaluation of spontaneous
speech and comprehension was also performed. The
language function was lateralized by the presence of
spontaneous speech and comprehension. The criteria
of memory failure were below five items recalled in
dominant side injection and below six items recalled in
non-dominant side injection. The criterion of signifi-
cant interside difference was that the asymmetry score
be above four items recalled. After confirming normal-
ization of language, speech, hemiparesis, and EEG
abnormality, memory function was assessed by free
recall and multiple choice recognition. Injection on
the other side was performed after the EEG was nor-
malized and at least 30 minutes after the first injection.
Neuropsychological testing included general intel-
lectual assessment, tests of attention, memory, lan-
guage and reasoning, visuospatial or perceptual test-
ing, affective testing and sensory-motor examination
through clinical interviews.
Seven of the 71 patients required invasive monitor-
ing because of indeterminate or discordant results on
the pre-surgical tests.
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localization
If each diagnostic test resulted in localization or lat-
eralization of the surgically resected medial temporal
lobe, the term true is used; localization or lateraliza-
tion to the opposite site, false; neither localization nor
lateralization, inconclusive; and unchecked.
Statistical analysis
Surgical outcome was classified according to the clas-
sification of J. Engel20. Class I (‘seizure free’) in-
cludes those who have been seizure free since surgery,
as well as those who experienced auras only. It also in-
cludes atypical generalized seizures with withdrawal
of antiepileptic medication, or at least 2 years of
seizure-free remission with no further seizures up
to the most recent follow-up. Class II indicates rare
seizures. Class III indicates a worthwhile improve-
ment, i.e. at least a 90% improvement in seizure fre-
quency compared with pre-operative status. Class IV
denotes no worthwhile improvement.
The sensitivity estimations were acquired by divid-
ing the numbers of the true localized or lateralized En-
gel Class I group by the numbers of the Engel Class I
group including the inconclusive group, and the true
and false localized or lateralized groups. The speci-
ficity estimations were acquired by dividing the num-
bers of the false localized or lateralized Engel Class
II–IV group by the numbers of the Engel Class II–
IV group. Logistic regression techniques were applied
to assess the relationships between pre-operative pre-
dictors and surgical outcome. A chi-squared test was
used to evaluate each diagnostic test vs. seizure out-
come. The logit log linear model was used for com-
paring MRI with the other diagnostic tests. This lo-
gistic regression method can be used to describe the
relationship between a dichotomous response variable
and a set of explanatory variables. Given a sample
of n subjects, let Y j denote the binary response vari-
ate of interest and χ j = (χ1 j , χ2 j , . . . , χk j ) be the
vector for explanatory variables corresponding to the
j th individual selected in the sample. βi is the regres-
sion coefficient of the j th individual. Let the condi-
tional probability that the response outcome is present,
Pr = {Y j = 1|X j = χi }, be denoted by Pr(χ j ),
then the logistic regression model can be written as
below21, 22.
Pr(χi j ) =
exp
(
β0 +∑ki=1 βiχi j)
1+ exp
(
β0 +∑ki=1 βiχi j) .
In our use of the logit log–linear model, P < 0.05 was
considered statistically significant.RESULTS
Pathology
The surgically excised temporal lobes showed vary-
ing degrees of hippocampal neuronal loss with glio-
sis and contained no pathologically verified mass le-
sions. Sixty-one patients had hippocampal sclerosis.
Fifty patients showed cortical dysplasia in the tempo-
ral lobe. One patient had no pathologic report. One pa-
tient had gliosis only, and one patient showed an old
contusion. Forty-seven patients had hippocampal scle-
rosis with mild cortical dysplasia. Three patients with
hippocampal sclerosis were found to have normal find-
ings on MRI.
Surgical outcome
Sixty-six patients (92.9%) who have been seizure free
since surgery had Engel Class I outcomes. Two pa-
tients (2.8%) who had rare seizures had Engel Class II
outcomes. Three patients (4.3%) who had worth-
while improvement in seizure frequency, compared
with their pre-operative status, had Engel Class III
outcomes (Table 1). Two patients had post-operative
hemiparesis with intracranial hemorrhage and two pa-
tients suffered from surgical wound infections. Thus
the mortality was 0% and the permanent morbidity
was 2.8% (Table 2). The sensitivities for various di-
agnostic tests were as follows: MRI, 93%; PET, 83%;
interictal EEG, 87%; video-EEG, 89%; ictal SPECT,
76%; Wada test, 60%; neuropsychological test, 55%;
interictal SPECT, 37%. The specificities were as fol-
lows: MRI, 13%; PET, 25%; interictal EEG, 13%;
video-EEG, 40%; ictal SPECT, 25%; Wada test, 33%;
neuropsychological test, 50%; interictal SPECT, 75%
(Table 3). Also, the positive predictive values for these
tests were as follows: MRI, 89%; PET, 89%; interic-
tal EEG, 89%; video-EEG, 95%; ictal SPECT, 91%;
Wada test, 90%; neuropsychological test, 90%; inter-
ictal SPECT, 92%. The negative predictive values for
these tests were as follows: MRI, 20%; PET, 17%;
interictal EEG, 11%; video-EEG, 22%; ictal SPECT,
9%; Wada test, 7%; neuropsychological test, 12%; in-
terictal SPECT, 13% (Table 4). No statistically signifi-
cant relationships were found between the surgical
outcomes and the localization results from the vari-
ous diagnostic tests (R-by-C table, P > 0.05) (Ta-
ble 5). However, in the logit log–linear model com-
paring MRI with the other tests, SPECT, neuropsy-
chological testing, and the Wada test had less predic-
tive values (P < 0.01). Interictal EEG, video-EEG,
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Table 5: The result of chi-squared testing (each diagnostic
test and Engel Class I vs. Engel Class II–IV).
Diagnostic test P-value
Interictal EEG 0.987
Video-EEG 0.079
MRI 0.723
PET 0.561
Ictal SPECT 0.978
Interictal SPECT 0.502
Neuropsychological test 0.863
Wada test 0.738and PET had comparable predictive values for En-
gel Class I with MRI (P > 0.05) (Table 6). Like
the cases in Casino et al.13 , most cases in our series
could be localized using only MRI and EEG. However,
even the false localized group (N-8, Engel Class I:
87.5%) had comparable prognoses to the true local-
ized group (N = 63, Engel Class I: 93%) (Tables 7
and 8). Therefore, we conclude that cases with good
prognoses could be lost if only EEG and MRI are used
pre-operatively.Table 1: Post-operative outcome.
Engel Class No. Percentage
I 66 92.9
II 2 2.8
III 3 4.3
IV 0 0
Table 2: Post-operative complications.
Percentage No. (n = 71)
Mortality 0.0 0
Morbidity 5.6 4
Post-operative hemiparesis 2.8 2
Wound infection 2.8 2
Permanent complications.
Table 3: Sensitivities and specificities.
Diagnostic test Sensitivities Specificities
Interictal EEG 87% (55/63) 13% (1/8)
Video-EEG 89% (56/63) 40% (2/5)
MRI 93% (59/63) 13% (1/8)
PET 83% (50/60) 25% (2/8)
Ictal SPECT 76% (31/41) 25% (1/4)
Interictal SPECT 37% (23/62) 75% (6/8)
Neuropsychological test 55% (18/33) 50% (2/4)
Wada test 60% (37/62) 33% (2/6)
Table 4: Positive and negative predictive values.
Diagnostic test Positive predictive value n
Interictal EEG 89% (55/62)
Video-EEG 95% (56/59)
MRI 89% (59/66)
PET 89% (50/56)
Ictal SPECT 91% (31/34)
Interictal SPECT 92% (23/25)
Neuropsychological test 90% (18/20)
Wada test 90% (37/41)
Table 6: The logit log–linear model for comparison with MRI.
Diagnostic test P-value
Interictal EEG 0.4924
Video-EEG 0.2030
PET 0.2678
Ictal SPECT 0.0236
Interictal SPECT 0.0001
Neuropsychological test 0.0001
Wada test 0.0001
Table 7: Localization with interictal EEG or video-EEG
monitoring, and MRI (n = 63).
Engel Class No. Percentage
I 59 93.7
II 1 1.6
III 3 4.7
IV 0 0
Table 8: No localization with interictal EEG or video-EEG
monitoring, and MRI (n = 8).
Engel Class No. Percentage
I 7 87.5
II 1 12.5
III 0 0
IV 0 0DISCUSSION
Precise localization and removal of the epileptogenic
focus is the ultimate treatment goal in medically in-
tractable epilepsy patients. Until now, no single diag-
nostic test has been shown to be solely sufficient in
localizing the site to be surgically resected. During
the 40 years that EEG was used to localize epilepto-
genic foci, false localization commonly occurred. The
irritative zone may correspond to the site of seizure
onset, but it does not always approximate the criti-
cal epileptogenic brain region23–25. After the use of
depth electrodes, video monitoring, and subdural elec-
trodes began, diagnostic accuracy increased. However,
other problems concerning time and cost arose. In the
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PET had the highest diagnostic sensitivity in tempo-
ral lobe epilepsy (TLE) (84% vs. 66% for SPECT,
55% for qualitative MRI, 71% for quantitative MRI)
while SPECT has the highest sensitivity in extratem-
poral epilepsy (ETE) (60% vs. 43% for MRI and 33%
for PET). The highest diagnostic sensitivity and speci-
ficity were achieved by ictal imaging with SPECT
(90% in TLE, 81% in ETE). The techniques, however,
were not always redundant. One reason for the wide
discrepancy of results between TLE and ETE might be
the differing pathologic substrates. A literature review
suggests that PET and MRI are much more sensitive
to MTS than SPECT (100%, 95% vs. 70%)2–8.
The use of these modalities can save the expense of
pre-operative EEG evaluation, and invasive and risky
diagnostic tests. For example, the use of depth elec-
trodes and subdural electrodes can be omitted when
using PET and MRI. The principle of PET is based on
the functional state of hypometabolic interictal epilep-
togenic foci, and its sensitivity is high, although there
is no definite anatomical abnormality. Because spa-
tial discrimination has improved recently, PET’s sen-
sitivity is approximately 85%, and its specificity ap-
proaches 90% to 98%14, 26. On the other hand, MRI is
sensitive when there are structural changes27. In me-
dial TLE, it has been found that the sensitivity of MRI
ranges from 75% to 86%, and its specificity ranges
from 64% to 100%9, 10, 12, 13.
In our study, the specificity of MRI was 13% and
the specificity of PET was 25%. These numbers are
lower than those in other studies. There could be sev-
eral explanations for this, but case selection bias may
be the biggest influence. Another possibility may be
due to our protocol. Even when EEG, MRI or PET
failed to localize concordantly, we did perform the
surgery if two of the three tests succeeded to local-
ize and the other test was inconclusive. We also per-
formed surgery if invasive monitoring resulted in con-
clusive data, even when two of the three tests suc-
ceeded in localizing and the other test had a discordant
result. Another possible reason for our lower numbers
may be the presence of hippocampal sclerosis without
MRI-detectable abnormality. The last possible reason
is that the false localized group included an inconclu-
sive group as well as the false localized group itself,
unlike other studies. Low negative predictive values
may also have been influenced by the same reasons.
Our study differs from others in the criteria for
diagnosing medical temporal lobe epilepsy. In other
studies, the correct localization was based on EEG
results only10, 13, 28. Theoretically, however, to diag-
nose medial temporal lobe epilepsy, the patient should
be seizure free after removal of the medial tempo-
ral lobe. This study is based on the premise that
only patients who are seizure free after removal ofthe medial temporal lobe had medial temporal lobe
epilepsy pre-operatively. Patients who are not seizure-
free post-operatively did not have medial temporal
lobe epilepsy. Our data were analyzed with surgical
outcome as a gold standard.
In this study, we evaluated the localizing power of
each diagnostic test retrospectively. In medial tempo-
ral lobe epilepsy, we concluded that interictal EEG,
video-EEG, MRI, and PET are basically necessary
to localize epileptogenic foci pre-operatively, because
any one of them alone does not completely predict the
measure of seizure relief after surgery. Hence, these
tests supplement one another. However, ictal SPECT
had less diagnostic power than the above tests. A re-
view of the published literature suggests that inter-
ictal SPECT is less reliable than PET for detection
of medial temporal lobe epilepsy. However, it is im-
portant to note that further studies are needed be-
cause ictal SPECT has diagnostic validity, especially
in extra-temporal epilepsy, and may be more accurate
in diagnosing epilepsy associated with developmen-
tal lesions and tumors10. In addition, we think that
while pre-operative Wada tests or neuropsychological
tests have less diagnostic power, they are necessary
in predicting the post-operative changes of cognitive
and memory functions. Although the Wada test identi-
fies the language-dominant hemisphere and can evalu-
ate memory in the contralateral temporal lobe to as-
sure the safety of performing anterior temporal lobec-
tomy, it is not always used to lateralize the seizure fo-
cus29–32. Neuropsychological testing is employed dur-
ing pre-operative evaluation for epilepsy surgery to
measure functional deficits associated with unilateral
seizure onset15. Also, the outcomes of neuropsycho-
logical testing may be related to post-operative seizure
outcome, although the results have been mixed33. At
present, various diagnostic tests should be used to lo-
calize the epileptic focus correctly. In medial temporal
lobe epilepsy, the reason is that hippocampal sclerosis
may not be the only pathologic finding, and the cause
of hippocampal sclerosis is obscure. In addition, the
standard anterior temporal lobectomy with amygdalo-
hippocampectomy as our protocol of surgical treat-
ment can include the temporal neocortex. Therefore,
although patients who are diagnosed with medial tem-
poral lobe epilepsy are seizure free after the surgical
treatment, lateral TLE cannot be ruled out. In addi-
tion, if many variables are examined in a large number
of patients, and the indications and limits of each diag-
nostic test are clear, costs can be reduced.
CONCLUSION
We found that no diagnostic test was sufficient to diag-
nose medial temporal lobe epilepsy by itself. MRI had
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14. Manno, E. M., Sperling, M. R., Ding, X. et al. Predictors of
outcome after anterior temporal lobectomy: positron emission
tomography. Neurology 1994; 44 (Suppl. 12): 2331–2336.
15. Loring, D. W., Meador, K. J., Lee, G. P. et al. Wada memory
performance predicts seizure outcome following anterior tem-
poral lobectomy. Neurology 1994; 44 (Suppl. 12): 2322–2324.
16. Chung, M. Y., Walczak, T. S., Lewis, D. V., Dawson, D. V.
and Radtke, R. Temporal lobectomy and independent bitem-
poral interictal activity: what degree of lateralization is suffi-
cient? Epilepsia 1991; 32 (Suppl. 2): 195–201.
17. Armon, C., Radtke, R. A., Friedman, A. H. and Dawson, D. V.
Predictors of outcome of epilepsy surgery: multivariate analy-
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18. Cheon, J. E., Chang, K. H., Kim, H. D. et al. MR of hip-
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assessments. American Journal of Neuroradiology 1988; 19:the highest diagnostic sensitivity in non-lesional me-
dial temporal lobe epilepsy. However, it is suggested
that interictal EEG, video-EEG and PET be performed
with MRI. SPECT, neuropsychological tests and the
Wada test were found to have less predictive value and
limited diagnostic value.
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